Lv21
160 积分 2022-08-15 加入
Izalontamab brengitecan for HR+/HER2– breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial
9小时前
待确认
Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer
10小时前
已完结
Trastuzumab Rezetecan in ERBB2-Low Advanced Breast Cancer The HORIZON-Breast06 Randomized Clinical Trial
10小时前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
13小时前
已完结
Guanosine diphosphate-mannose suppresses homologous recombination repair and potentiates antitumor immunity in triple-negative breast cancer
14天前
已完结
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients Presenting With Locally Advanced Breast Cancer
19天前
已完结
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
27天前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
1个月前
已完结
Personalized mRNA Vaccine Spurs Lasting Immunity in TNBC
7个月前
已关闭
Evidence to Action — Single-Dose HPV Vaccination and Cervical HPV Infection
7个月前
已完结
皖公网安备34019202002308
